Brita Hobmann

Latest from Brita Hobmann

Adobe Stock
Gene Therapies
The Complex Calculus of Viral-Vector Facility Design: Considerations for Commercial Gene-Therapy ManufacturingThe Complex Calculus of Viral-Vector Facility Design: Considerations for Commercial Gene-Therapy Manufacturing
byBrian Gazaille, Allan Breamand 1 more
Oct 17, 2024

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: What if Your Supply Chain for Single-Use Equipment Was Robust?
Register Now: What if Your Supply Chain for Single-Use Equipment Was Robust?
Ask the Expert webcasts
ATE Webcasts
Register Now: Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency
Register Now: Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Tosoh AEX Method
Sponsored Content
Improved Safety in Ion Exchange Chromatography for Empty/Full Adeno-Associated Virus Analysis
Improved Safety in Ion Exchange Chromatography for Empty/Full Adeno-Associated Virus Analysis

Oct 14, 2024

LumaCyte LFC™
Sponsored Content
Label-Free Monitoring of T-Cell Activation Using Laser Force Cytology™
Label-Free Monitoring of T-Cell Activation Using Laser Force Cytology™

Oct 14, 2024

ValGenesis CSV to CSA
Sponsored Content
The Shift from CSV to CSA
The Shift from CSV to CSA

Oct 14, 2024